These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12488669)

  • 1. Macrolide resistance in group A Streptococcus.
    Freeman AF; Shulman ST
    Pediatr Infect Dis J; 2002 Dec; 21(12):1158-60. PubMed ID: 12488669
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes.
    Gagliotti C; Nobilio L; Milandri M; Moro ML;
    Clin Infect Dis; 2006 Apr; 42(8):1153-6. PubMed ID: 16575736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin resistance in Streptococcus pyogenes in Italy.
    Bassetti M; Manno G; Collidà A; Ferrando A; Gatti G; Ugolotti E; Cruciani M; Bassetti D
    Emerg Infect Dis; 2000; 6(2):180-3. PubMed ID: 10756153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide resistance in streptococcal pharyngitis.
    Lavergne V; Thibault L; Garceau R
    CMAJ; 2007 Jul; 177(2):177. PubMed ID: 17638961
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium.
    Van Heirstraeten L; Coenen S; Lammens C; Hens N; Goossens H; Malhotra-Kumar S
    Emerg Infect Dis; 2012 Sep; 18(9):1515-8. PubMed ID: 22932671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003.
    Malhotra-Kumar S; Lammens C; Chapelle S; Wijdooghe M; Piessens J; Van Herck K; Goossens H
    Emerg Infect Dis; 2005 Jun; 11(6):939-42. PubMed ID: 15963292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.
    Farrell DJ; Morrissey I; Bakker S; Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():39-47. PubMed ID: 12239227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating serotypes and antimicrobial sensitivity of Streptococcus pyogenes isolates from children in Cyprus.
    Koliou M; Ioannou Y; Efstratiou A; Hannidou N; Pieri V; Alexandrou M; Soteriades ES
    Clin Microbiol Infect; 2007 Jun; 13(6):645-7. PubMed ID: 17378928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).
    Michos A; Koutouzi FI; Tsakris A; Chatzichristou P; Koutouzis EI; Daikos GL; Stathi A; Syriopoulou VP
    J Antimicrob Chemother; 2016 Aug; 71(8):2113-7. PubMed ID: 27118782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C; van der Linden M; Reinert RR
    Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin.
    Betriu C; Culebras E; Redondo M; Rodríguez-Avial I; Gómez M; Boloix A; Picazo JJ
    J Antimicrob Chemother; 2002 Sep; 50(3):436-8. PubMed ID: 12205076
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of macrolide resistance in Streptococcus pyogenes collected in Serbia.
    Pavlovic L; Grego E; Sipetic-Grujicic S
    Jpn J Infect Dis; 2010 Jul; 63(4):275-6. PubMed ID: 20657068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update on antibiotic sensitive Streptococcus pyogenes in a pediatric population].
    Gené A; González-Cuevas A; Muñoz C; Luaces C; Latorre C
    Enferm Infecc Microbiol Clin; 2000 Mar; 18(3):144-5. PubMed ID: 10905020
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.
    Sakran W; Raz R; Chazan B; Koren A; Colodner R
    Int J Antimicrob Agents; 2004 May; 23(5):517-9. PubMed ID: 15120735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Streptococcus invasive locus (sil) and its relationship with macrolide resistance among group A Streptococcus strains.
    Billal DS; Hotomi M; Shimada J; Fujihara K; Ubukata K; Sugita R; Yamanaka N
    J Clin Microbiol; 2008 Apr; 46(4):1563-4. PubMed ID: 18287313
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations.
    Malbruny B; Nagai K; Coquemont M; Bozdogan B; Andrasevic AT; Hupkova H; Leclercq R; Appelbaum PC
    J Antimicrob Chemother; 2002 Jun; 49(6):935-9. PubMed ID: 12039885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of antimicrobial susceptibility of clinical isolates of Streptococcus pyogenes in Japan: report of a countrywide surveillance study.
    Hotomi M; Billal DS; Shimada J; Yamauchi K; Fujihara K; Yamanaka N;
    J Infect Chemother; 2005 Feb; 11(1):48-51. PubMed ID: 15729489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Macrolides in the treatment of streptococcal pharyngitis: not all effective].
    Alós JI
    Med Clin (Barc); 1999 Jan; 112(1):18-9. PubMed ID: 10027181
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of macrolide-resistance and comparative activity of telithromycin in streptococci in Austria, 1996-2002.
    Buxbaum A; Forsthuber S; Sauermann R; Gattringer R; Graninger W; Georgopoulos A;
    Int J Antimicrob Agents; 2004 Oct; 24(4):397-400. PubMed ID: 15380268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
    Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.